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Methods: We studied 65 pts (50 men, 15 women; moan age 52 ym) with 
EBCT who h0d Route myocordlol infarction (AMI) os their first cllnloal msnl. 
fostatlon of CAD. EBCT woe performed a mean of 25 day8 after Inferctlon, 
Results: CAC was pro80nt In 59 of 0`5 pie (91%), wlth n mann score of 
471) :L 551 (range 0-2401), el note, 4 of 0 pie without CAC hod one vessel 
CAD And Intracoronsry stont8 placed prior to EBCT, possibly masking CAC 
detection, The CAC 8~om, Adjusted for patient Age, w~s severn In 35 (54%); 
moderate In 11 (17%); and mild In 13 (20%~ pts, We hsve previously shown 
thst <10% of pie with CAC scores <400 have abnormal sims8 myocardial 
porfuslon scans, Importantly, 51% of our pie= had CAC scorer <400 And 80 
might not have boon dst~otod n9 having CAD by other 8Gm8nlng tost~, 6gob 
¢ttl a~omlso poduslon Imaging, 
Conclusion: Most pts who present with AMI as t1181r first manlf88tlltton ol
CAD have CAC, The I,~k el CAC, therefore, should predict A population ~t 
very low rl~k lot CAD and sobsequont oardlso events, 
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~ 3 , ~  Yurm Follow,up of Asymptomatl© 11311 Adults 
Undergoing Electron Basm CT (EBCT) of the 
Comn#~ Artsrlsl 
Y, A~fl, LA, ~podnm, K, Goods,n, A, Lledo, ~, 9herman, A,D, QuAsi, St, 
Fr'dncl~ H~pft~ll, Rotten, N, Y, USA 
In order to determine the Intermediate term pmgnostlo aoC:ur~Cy (~t EaCT 
ds A l!cmonlng test for coronary artow disease, wo qllerlod 1173 initially 
Asymplomnlto ~dult~ 3,0, yearn (range 38 to 47 months) alter sonnntngl, t136 
(97%) replied; olforls to centaur the missing subjects mml~ln gndm way, 
Al the time of sosnnlng, me~n age was ~3 ± 11 yasm sad median (25%, 
75%) Corons~ ¢alclt~m scorn (CC~) wpls 4 (0, 9B), At follow.up, 40 patlent~ 
h~d 8usteltne~l camlovnscular doeth (2), nonfatal MI (14), CABG (14), or 
PTCA (10) Iovent rate 3,5%1, Medteln CCS was 655 (lUll, 872) among thos~ 
with events emd 4 (0, £tl) among those without events (p -: 0`.0001) 
Sensitivity, specificity, positive snd negative pmdiotivo values, overall an. 
curacy (OA) and odds ratios Am tabtllated below 1o1 events, CCS thresholds, 
and group8 of Interest, 
EvonlatGmol~ CC~ 9one Spoc PPV NPV OA OR P 
NPNI : 100 ~80~ 0,85 016 000~ 085 23 - 00001 
MI, do~th/NI 160 081 08~ 0 07 0991' 0.84 22 .00001 
Atl/AIt :600 0,55 085 0~a 0983 084 24 • 00001 
All/Men ;100 08~ 084 01a 0091 085 25 ,00001 
AlINVom~n .160 011 0.SB 0,11 0893 087 18 -0.001 
In asymplomalic, ~ppamntly hoallhy adults, EBCT is highly predictive oi 
cardiovascular events over the ensuing 3 to 4 years. 
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~ Incidence and Predlctom of Anglographlc 
Restanosis snd Reoccluslon Alter Primary Infarct 
Slanting - Core lab Analysis From the PAMI Stent 
Pilot Study 
J. Griffin, B, Brodie, M-C. Morice, C. Costantini, J. Popma, P,A. Overlie, 
F, St, Gear, J.G, Kenersoo, A. Merrill, S. Thoodostou, J.A, McDonnell, 
W.W, O'NeilL C,L, Gnnos, G,W. Stone. The Cardiovascular Instatute, El 
Camino Hospital Mountain View, CA, USA 
Acute infarct stenting has the potential to reduce 1he high rate of restenosis 
after prima~ PTCA, reported in 5 poor series to be 37%.--49% (including 
9%-13% infarct artery mOcclusion). In the prospective PAMI Steal Pilot Trial, 
stenting was performed in 240 consecutive pts with AMI and eligible vessels 
at 9 centers (98% success rate). A mean of 1 4 i 0.7 slants were implanted 
per pt (range 1-7) at 17.3 ~ 2.4 aim.; 97% were Palmaz-Schatz, Of 229 
stented pts discharged without in-hAsp. CABG, angiographic follow.up was 
performeO m 176 pts (77%) at mean time oi 7,7 ± 3.4 months Index and 
follow-up films were analyzed at an independent core lab (Wash. HAsp. 
Cntr.). TIMI-3 flow (core lab) was restored in 95,5% of pts after stenting. 
Angiogmphic measures are shown in table. 
The late loss index was 0.33 J: 0.36. Restenosis (DS >50%) occurred 
in 25,2% of pts, including 5.6% infamt artery reocclusion, 51 procedural, 
technical and angiographic variables were examined lor their relationship 
to reslonosis. The only correlate of restenosis was the number of stents 
Pro Imm, pest Follow.up 
Reference ~og (ms) 3,08 t. 0,0~ 3,19 t O51 3,09 t 0,55 
MLD (ms) 0,27 :*- 0,56 2,85 t. 0,51 202  ¢ 091 
Oinmntor Mono~is (%) 89,1 t 180 10,4 t 120 340  ~ 270 
implsntod (20,6% with 1 stoat, 32,5% with 2 8tent8 and 50,0% with '~3 
stonts, p = 0,07), The only pmdlotor of reo¢¢luslon waA the final I~lloon 
dlamstor (12,1% with ~3,0 mm bsl, ve, I~,1% with ~,~1,25 mm I~1,, p =, 0,01), 
Conclusions: The date from this 18rg0, pro~p~tlve multt¢entAr 8lAdY 8gO, 
goats thst prlmAty 8tenting In AMI mdg~ msten~i8 And infarct Artery 
mocd~mlon Compared to prlmsq/PTCA Alone, 
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~ Pr!mary Anglopluty for Acute Myocardial Infamtlon 
at Hospitals With No Surgery On-81te: The 
Prospective Mull!center PAMI,No SOIl Reg!Mry 
tP, Whmlon, J,D, Johnston, M,A, Ttlrco, J, ~!ithet, D,C~ Lew, W, Oi!!no~i, 
5,K, Slnghi, M Graham, L. Grihes, W,D, Weaver, C,L Qltnes, Wdl~n 
80~ltt11~rlt Ho.~fat, Royal O~k, MI and Exeter Hosl:~tat, ~ le t ,  NH, U~°~ 
Prtm~n/angioplasly (PA) prowdes supmtor Outcomes ~red  to throm. 
holysi8 (TL) tar patients (pts) with acute myocardia! inlamtion (AMI), b~d 
ilS I~tential for widespread use.especially in community hospitals with no 
pardine surgoly on.site (No SOS}.may be limited. This issue is even more 
relevant in thmmbolylio.eligible (TL.E) pls, tar whom an almmarive mpadu- 
sion me~lalkty el(ists. We sought to investigate the safety end elflicacy O1 PA 
in hiQtl,llsk TL-IE pta when pedolmed at hospitals wlth No SOS, 
I~thods: We orgafltted Anational registly a114 community besl~tals with 
No SOS whom expelienced operates mulinety porfom~ PA around-the-clock 
as tirol-line treatment far pts with AML To allow comparison to the ongmn9 
AIR PAMt Trial, pts were prospectively consented if they met AIR PAMi 
criteria: TL-E end at high risk (age 270, anlenor MI, LBBB, HR >100, BP 
.: 100, Kiilip Class, 2-.3) without shock, 
Re,suits: 266 TL-E pts with high-risk AMI had emergent calh with PTC/~ 
slant standby, tar which monitored data am available in 164. Enrollment is 
ongoing, 41% worn ~70 ym old; 46% had antenor MI. Due to No SOS. 
infarct arteries were no1 dilated if they had initial TIMI 3 flow (n = 18) or 
worn technically tnapprepnate (n = 6). Thus, PTCA was performed in 140 
(85)%, with stenhog in 46% el these. The mean time trem ER to oath was 
100 sin. Precoduml success rate" (TIMI 2 flow and <50% residaal) was 
98.6%, Emergent ransfer tar CABG was required in 2 pts (1.4%): one for 
a PA complication, and one for high-risk anatomy with no PTCA performed. 
Mean length-el-stay was 5,4 days. The combined pnman] endpoint oocuned 
in 4 pts (2.9%): in-hospital death in 2 (1.4%); CK-MB rmelevation ~n none: 
and CVA in 2 (1.4%). No pt died because o1 a complicalion ut oath o¢ 
PTCA, 
Conclusion: Tbls hmt report tram a prospective multicentor egistry el 
primary angioplasty at hospitals without celiac surgew indicates that PTCA 
in this setting can be provided solely and effectively in high-risk patients, wtlh 
outcomes that compare yen/favorably to those repotted Ires high-volume 
surgical centare. The lack st cardiac surges/need not limit the application st 
this valuable sodality in the treatment of AMI, 
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~ Angloplasty Versus Thrombolytlcs for Patients 
Presenting With Congestive Heart Failure; GUSTO 
lib Substudy Findings 
J.S. Hochman, WA. Jaber, E.R. Bates, D.A. Criger, J. Boland. 
C. VassanoIli, EJ. Topoi, S.G. Ellis. St. Luke's. Roosevelt Hospital Center. 
Columbia Universi~ NY, NY, USA 
Background: Although tnrombolytic therapy has reduced mortality for patients 
presenting with AMt and CHF, adverse events rates remain high. Pnor repeals 
suggest a greater benefit for direct PTCA over thrombotysis for patients with 
CHF. 
Killip II/tll Kiilip I 
PTCA IPA RR, CI PTCA IPA RR. Cl 
n = 46 n = 49 (95%) n = 509 n = 525 (95%) 
30 day death, 10.2% 21,700 0.41 8.9% 12.8% 0.68 
rO-MI, CVA (0.13-1.31) (0.44-0.89) 
p=016 p=0045 
6rnonlhdeath 12.2% 24.4% 043 6.6% 7.0% 0.94 
(0.15-I.29) (0.58-1.53) 
p= 0.18 p = 0.90 
IABP use 20.4% 109% p = 0.26 12.8°'o 6.3% p = 0.0004 
